We had the honor of hosting Prof. Andreas Habenicht from the Institute for Cardiovascular Prevention (IPEK) at Ludwig-Maximilians University for a wonderful talk on “Neuroimmune Cardiovascular Circuits” at the Institute for Precision Medicine.

​

During his talk, Prof. Andreas Habenicht shared about the fantastic story about their recent research on neuroimmune-arterial interfaces and their role in regulating the progression of atherosclerosis. His team has provided proof-of-principle evidence that the nervous system can sense and affect atherosclerosis via proxy actors, i.e. immune cell aggregates in the adventitia. His group recently identified and functionally delineated interactions between nerves in the adventitia, artery tertiary lymphoid organs (ATLOs) and arteries that we termed neuroimmune cardiovascular interfaces (NICIs).

​

Prof. Andreas habenicht is a full professor at the Institute for Cardiovascular Prevention (IPEK) at Ludwig-Maximilians University. His lab has achieved several landmark discoveries in atherosclerosis in recent years, including: (i) elucidating neuroimmune-cardiovascular crosstalk in atherosclerosis; (ii) comprehensively characterizing artery tertiary lymphoid organs in atherosclerosis ;(iii) identifying ApoE as a direct checkpoint of complement cascade activation; (iv) demonstrating the broad tolerance breakdown of T cells in atherosclerosis.